Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Controlled Release

• Publication date

  2009-11-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2009.06.034PMID 19595724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNAi and chromatin in T cell development and function.

  2008cited by this paper
• RNA interference and cancer: endogenous pathways and therapeutic approaches.

  2008cited by this paper
• RNAi therapeutics: an update on delivery.

  2008cited by this paper
• An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.

  2008cited by this paper
• The design of vectors for RNAi delivery system.

  2008cited by this paper
• Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes.

  2008cited by this paper
• RNA interference: An emerging generation of biologicals

  2008cited by this paper
• Lipoplex morphologies and their influences on transfection efficiency in gene delivery.

  2007cited by this paper
• DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery studied by circular dichroism and other biophysical techniques.

  2007cited by this paper
• Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.

  2007cited by this paper
• Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.

  2007cited by this paper
• Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes.

  2007cited by this paper
• RNAi silencing in mouse models of neurodegenerative diseases.

  2007cited by this paper
• Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference1

  2007cited by this paper
• Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.

  2007cited by this paper
• Harnessing in vivo siRNA delivery for drug discovery and therapeutic development

  2006cited by this paper
• Therapeutic potential of RNAi in metabolic diseases.

  2006cited by this paper
• Synthesis of NTA3-DTDA — A Chelator-Lipid that Promotes Stable Binding of His-Tagged Proteins to Membranes

  2006cited by this paper
• Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells

  2006cited by this paper
• Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.

  2006cited by this paper
• Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.

  2006cited by this paper
• Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

  2005cited by this paper
• Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.

  2005cited by this paper
• The therapeutic potential of RNA interference

  2005cited by this paper
• In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice.

  2005cited by this paper
• The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.

  2005cited by this paper
• Intracellular trafficking of nonviral vectors

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Co-Transfection of Messenger RNA and siRNA as a Method to Study the Efficiency of siRNA

  2005cited by this paper
• In Vivo Application of RNA Interference: From Functional Genomics to Therapeutics

  2005cited by this paper
• Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo.

  2005cited by this paper
• Gene delivery to dendritic cells facilitated by a tumor necrosis factor alpha-competing peptide.

  2004cited by this paper
• Targeting Dendritic Cells with Antigen-Containing Liposomes

  2004cited by this paper
• Suppression of tumor growth and metastasis by a VEGFR‐1 antagonizing peptide identified from a phage display library

  2004cited by this paper
• Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA12

  2003cited by this paper
• Gene silencing by systemic delivery of synthetic siRNAs in adult mice.

  2003cited by this paper
• RNA interference targeting Fas protects mice from fulminant hepatitis

  2003cited by this paper
• Biophysical Aspects of Using Liposomes as Delivery Vehicles

  2002cited by this paper
• A novel approach for modifying tumor cell‐derived plasma membrane vesicles to contain encapsulated IL‐2 and engrafted costimulatory molecules for use in tumor immunotherapy

  2002cited by this paper
• Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins*

  2002cited by this paper
• Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.

  2002cited by this paper
• Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.

  2001cited by this paper
• A novel system for convenient detection of low‐affinity receptor–ligand interactions: Chelator‐lipid liposomes engrafted with recombinant CD4 bind to cells expressing MHC class II

  2001cited by this paper
• Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.

  2001cited by this paper
• Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development1

  2000cited by this paper
• The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer.

  1995cited by this paper
• Liposomes revisited

  1995cited by this paper
• Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.

  1995cited by this paper
• Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.

  1991cited by this paper

• MCT4 knockdown by tumor microenvironment-responsive nanoparticles remodels the cytokine profile and eradicates aggressive breast cancer cells.

  2024cites this paper
• Lipoprotein Particles as Shuttles for Hydrophilic Cargo

  2023cites this paper
• Immune Cells Activating Biotin-Decorated PLGA Protein Carrier.

  2022cites this paper
• pH-responsive aminolipid nanocarriers for antimicrobial peptide delivery.

  2021cites this paper
• Using peptides to promote delivery and improve anti-tumour efficacy of liposomal drug

  2021cites this paper
• 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 2

  2019cites this paper
• Nanoparticle delivery systems for siRNA-based therapeutics.

  2016cites this paper
• Liposomes as nanomedical devices

  2015cites this paper
• Combinatorial peptide libraries: mining for cell-binding peptides.

  2014cites this paper
• Ligation Strategies for Targeting Liposomal Nanocarriers

  2014cites this paper
• Cutaneous Cell- and Gene-Based Therapies for Inherited and Acquired Skin Disorders

  2014cites this paper
• Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery

  2012cites this paper
• The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies.

  2012cites this paper
• Physicochemical characterization techniques for lipid based delivery systems for siRNA.

  2012cites this paper
• Innovation in Vaccinology

  2012cites this paper
• Lipid-anchored drugs for delivery into subcellular compartments.

  2012cites this paper
• Nanomedicine in Nucleic Acid Therapy

  2012cites this paper
• Liposomes and Other Nanoparticles as Cancer Vaccines and Immunotherapeutics

  2012cites this paper
• Gene Delivery Systems: Tailoring Vectors to Reach Specific Tissues

  2011cites this paper
• Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid

  2011cites this paper
• The Mechanical Agitation Method of Gene Transfer for Ex-Vivo Gene Therapy

  2011cites this paper
• Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.

  2011cites this paper
• Nano to micro delivery systems: targeting angiogenesis in brain tumors

  2010influential citation
• Dynamics of supported lipid bilayer deposition from vesicle suspensions.

  2010cites this paper
• Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.

  2010cites this paper
• Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.

  2010cites this paper
• CLINICAL PHARMACOKINETIC ASPECTS OF STEALTH LIPOSOMES: AREVIEW

  2010cites this paper
• Lipidic Systems for In Vivo siRNA Delivery

  2009cites this paper